Exelixis, Inc. Awards Us “2025 CDMO of the Year”

2026/02/09

We are pleased to announce that we have received the “2025 CDMO of the Year Award” from our valued global customer, Exelixis, Inc.
This award reflects the high level of trust and recognition we have earned from an overseas pharmaceutical partner for our performance as a Contract Development and Manufacturing Organization (CDMO).
Our technical expertise, quality standards, supply reliability, and commitment to delivering value to our customers were highly evaluated.
We are honored that our continuous efforts and strong partnership with Exelixis, Inc. have been acknowledged on a global stage.
While we greatly appreciate this recognition from an international customer, we do not consider it a final achievement.
We remain fully committed to further enhancing our services, strengthening our technical capabilities, and responding flexibly and swiftly to the evolving needs of customers worldwide.
As a trusted CDMO partner, we will continue to contribute to the advancement of healthcare through pharmaceutical development and manufacturing.